Form EFFECT Biodexa Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 17, 2025 5:30 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JZR Gold Inc. Closes Non-Brokered Private Placement Offering of Units
- Nano Dimension Board Sets the Record Straight on Murchinson's Self-Interested and Destructive Campaign
- EquipmentShare Raises 2026 Financial Outlook on Strong Customer Demand and Authorizes $500 Million Share Repurchase Program
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
